Mangrove Partners Collegium Pharmaceutical, Inc Transaction History

Mangrove Partners

  • $890 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$19.25 - $26.1 $3.12 Million - $4.23 Million
-162,003 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$17.83 - $22.29 $7.7 Million - $9.62 Million
-431,738 Reduced 72.71%
162,003 $3.25 Million
Q3 2020

Nov 16, 2020
BUY
$15.78 - $20.82 $9.37 Million - $12.4 Million
593,741 New
593,741 $12.4 Million

Others Institutions Holding COLL

# of Institutions
236
Shares Held
39.4M
Call Options Held
84.2K
Put Options Held
18.6K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.33B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email